Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Growth factor epidermal

EGF may also find a novel agricultural application in the defleecing of sheep. Administration of EGF to sheep has a transient effect on the wool follicle bulb cell, which results in a weakening of the root that holds the wool in place. Although novel, this approach to defleecing is unlikely to be economically attractive. [Pg.283]


Whereas epidermal growth factor (EGF) enhances the radiosensitivity of human squamous ceU carcinoma cells in vitro (197), addition of EGF to hormone-deprived MCE-7 breast cancer cells prior to irradiation results ia iacreased radioresistance (198). An anti-EGE-receptor monoclonal antibody blocks the abiUty of EGE to enhance growth and radioresistance. Tumor cells, the growth of which is stimulated by EGE, appear to be protected those where growth is iohibited are sensitized (198). [Pg.496]

Figure 2.19 Organization of polypeptide chains into domains. Small protein molecules like the epidermal growth factor, EGF, comprise only one domain. Others, like the serine proteinase chymotrypsin, are arranged in two domains that are required to form a functional unit (see Chapter 11). Many of the proteins that are involved in blood coagulation and fibrinolysis, such as urokinase, factor IX, and plasminogen, have long polypeptide chains that comprise different combinations of domains homologous to EGF and serine proteinases and, in addition, calcium-binding domains and Kringle domains. Figure 2.19 Organization of polypeptide chains into domains. Small protein molecules like the epidermal growth factor, EGF, comprise only one domain. Others, like the serine proteinase chymotrypsin, are arranged in two domains that are required to form a functional unit (see Chapter 11). Many of the proteins that are involved in blood coagulation and fibrinolysis, such as urokinase, factor IX, and plasminogen, have long polypeptide chains that comprise different combinations of domains homologous to EGF and serine proteinases and, in addition, calcium-binding domains and Kringle domains.
Domains that are homologous to the epidermal growth factor, EGF, which is a small polypeptide chain of 53 amino acids. [Pg.29]

FIGURE 6.38 A sampling of proteins that consist of mosaics of individual protein modules. The modules shown include 7CG, a module containing 7-carboxyglutamate residues G, an epidermal growth-factor-like module K, the kringle domain, named for a Danish pastry ... [Pg.196]

These interactions involve adhesion proteins called selectins, which are found both on the rolling leukocytes and on the endothelial cells of the vascular walls. Selectins have a characteristic domain structure, consisting of an N-terminal extracellular lectin domain, a single epidermal growth factor (EGR) domain, a series of two to nine short consensus repeat (SCR) domains, a single transmembrane segment, and a short cytoplasmic domain. Lectin domains, first characterized in plants, bind carbohydrates... [Pg.283]

III. Tyr protein kinases A. Cytosolic tyrosine kinases src, fgr, abl, etc.) B. Receptor tyrosine kinases (RTKs) Plasma membrane receptors for hormones such as epidermal growth factor (EGF) or platelet-derived growth factor (PDGE) Raf (a protein kinase)... [Pg.467]

Investigation of cytotoxic antitumor activity of phthalocyanin conjugates with epidermal growth factor 98MI55. [Pg.233]

The two isozymes are both homodimers, composed of approximately 600 amino acids and possess approximately 60% homology. The three-dimensional structures of COX-1 and COX-2 are very similar. Each one consists of three independent units an epidermal growth factor-like domain, a membrane-binding section and an enzymic domain. The catalytic sites and the residues immediately adjacent are identical but for two small but crucial variations that result in an increase in the volume of the COX-2-active site, enabling it to accept inhibitor-molecules larger than those that could be accommodated in the COX-1 molecule. [Pg.404]

The epidermal growth factor receptor 2 (HER-2) is a protein found on the surface of cells. Heterodimerization of HER-2 activates the enzyme tyrosine kinase, triggering reactions that cause the cells to grow and multiply. HER-2 is found at abnormally high levels on the surface of many types of cancer cells, which may divide excessively. Antibodies targeting HER-2 (e.g., trastuzumab) are used as antineoplastic agents. [Pg.478]

Epidermal Growth Factor Receptor Family Growth Factors... [Pg.482]

The regulation of NHE2 is multifactorial. Chronic exposure to nitric oxide and gamma-interferon decrease NHE2 activity, whereas metabolic acidosis and chronic stimulation with epidermal growth factor (EGF) increase activity. [Pg.810]

Harari PM (2004) Epidermal growth factor receptor inhibition strategies in oncology. Endocr. Relat. Cancer 11 689-708... [Pg.1257]

Epidermal Growth Factor (EGF) Receptor Family Epidermal Growth Factor Receptor 2 (ErbB2) Epidural (Space)... [Pg.1491]


See other pages where Growth factor epidermal is mentioned: [Pg.221]    [Pg.272]    [Pg.281]    [Pg.282]    [Pg.159]    [Pg.290]    [Pg.292]    [Pg.834]    [Pg.156]    [Pg.370]    [Pg.457]    [Pg.474]    [Pg.478]    [Pg.478]    [Pg.478]    [Pg.478]    [Pg.478]    [Pg.505]    [Pg.565]    [Pg.566]    [Pg.604]    [Pg.604]    [Pg.706]    [Pg.709]    [Pg.742]    [Pg.815]    [Pg.817]    [Pg.968]    [Pg.1010]    [Pg.1067]    [Pg.1076]    [Pg.1192]    [Pg.1206]    [Pg.1254]    [Pg.1258]    [Pg.1275]    [Pg.1491]   
See also in sourсe #XX -- [ Pg.29 ]

See also in sourсe #XX -- [ Pg.147 ]

See also in sourсe #XX -- [ Pg.263 ]

See also in sourсe #XX -- [ Pg.93 , Pg.133 , Pg.240 ]

See also in sourсe #XX -- [ Pg.481 , Pg.507 , Pg.507 ]

See also in sourсe #XX -- [ Pg.383 ]

See also in sourсe #XX -- [ Pg.65 ]

See also in sourсe #XX -- [ Pg.19 , Pg.168 , Pg.231 , Pg.269 , Pg.270 , Pg.273 ]

See also in sourсe #XX -- [ Pg.192 , Pg.278 , Pg.383 ]

See also in sourсe #XX -- [ Pg.252 , Pg.259 ]

See also in sourсe #XX -- [ Pg.22 , Pg.29 , Pg.31 , Pg.45 , Pg.46 , Pg.54 , Pg.93 , Pg.108 ]

See also in sourсe #XX -- [ Pg.544 , Pg.571 , Pg.1753 ]

See also in sourсe #XX -- [ Pg.766 ]

See also in sourсe #XX -- [ Pg.59 , Pg.591 , Pg.858 ]

See also in sourсe #XX -- [ Pg.2 , Pg.2 , Pg.6 , Pg.21 , Pg.75 , Pg.76 , Pg.220 , Pg.221 , Pg.279 ]

See also in sourсe #XX -- [ Pg.334 ]

See also in sourсe #XX -- [ Pg.22 ]

See also in sourсe #XX -- [ Pg.99 ]

See also in sourсe #XX -- [ Pg.85 ]

See also in sourсe #XX -- [ Pg.377 ]

See also in sourсe #XX -- [ Pg.59 , Pg.100 ]

See also in sourсe #XX -- [ Pg.54 , Pg.73 ]

See also in sourсe #XX -- [ Pg.75 ]

See also in sourсe #XX -- [ Pg.180 ]

See also in sourсe #XX -- [ Pg.3 , Pg.8 , Pg.300 , Pg.330 , Pg.334 , Pg.521 ]

See also in sourсe #XX -- [ Pg.54 ]

See also in sourсe #XX -- [ Pg.309 ]

See also in sourсe #XX -- [ Pg.306 ]

See also in sourсe #XX -- [ Pg.309 ]

See also in sourсe #XX -- [ Pg.4 ]

See also in sourсe #XX -- [ Pg.230 , Pg.549 ]

See also in sourсe #XX -- [ Pg.184 , Pg.290 ]

See also in sourсe #XX -- [ Pg.885 ]

See also in sourсe #XX -- [ Pg.544 , Pg.571 ]

See also in sourсe #XX -- [ Pg.824 ]

See also in sourсe #XX -- [ Pg.309 ]

See also in sourсe #XX -- [ Pg.104 ]

See also in sourсe #XX -- [ Pg.202 ]

See also in sourсe #XX -- [ Pg.316 ]

See also in sourсe #XX -- [ Pg.257 ]

See also in sourсe #XX -- [ Pg.203 ]

See also in sourсe #XX -- [ Pg.26 ]

See also in sourсe #XX -- [ Pg.109 , Pg.291 , Pg.317 , Pg.327 , Pg.482 ]

See also in sourсe #XX -- [ Pg.132 ]

See also in sourсe #XX -- [ Pg.126 , Pg.547 , Pg.554 ]

See also in sourсe #XX -- [ Pg.279 ]

See also in sourсe #XX -- [ Pg.312 ]

See also in sourсe #XX -- [ Pg.21 , Pg.25 , Pg.135 , Pg.766 ]

See also in sourсe #XX -- [ Pg.11 , Pg.63 , Pg.88 , Pg.92 ]

See also in sourсe #XX -- [ Pg.655 ]

See also in sourсe #XX -- [ Pg.135 ]

See also in sourсe #XX -- [ Pg.938 , Pg.1065 ]

See also in sourсe #XX -- [ Pg.544 , Pg.571 ]

See also in sourсe #XX -- [ Pg.195 ]

See also in sourсe #XX -- [ Pg.15 , Pg.441 ]

See also in sourсe #XX -- [ Pg.824 ]

See also in sourсe #XX -- [ Pg.378 ]

See also in sourсe #XX -- [ Pg.544 , Pg.571 ]

See also in sourсe #XX -- [ Pg.441 ]

See also in sourсe #XX -- [ Pg.245 ]

See also in sourсe #XX -- [ Pg.431 ]

See also in sourсe #XX -- [ Pg.125 , Pg.136 , Pg.167 , Pg.259 ]

See also in sourсe #XX -- [ Pg.417 ]

See also in sourсe #XX -- [ Pg.5 ]

See also in sourсe #XX -- [ Pg.5 , Pg.56 , Pg.173 , Pg.262 , Pg.278 , Pg.321 , Pg.322 , Pg.342 , Pg.459 , Pg.478 , Pg.522 , Pg.566 ]

See also in sourсe #XX -- [ Pg.188 ]

See also in sourсe #XX -- [ Pg.77 , Pg.516 ]

See also in sourсe #XX -- [ Pg.321 ]

See also in sourсe #XX -- [ Pg.250 ]

See also in sourсe #XX -- [ Pg.278 , Pg.279 , Pg.282 , Pg.283 , Pg.297 , Pg.299 , Pg.301 , Pg.302 , Pg.305 , Pg.306 ]

See also in sourсe #XX -- [ Pg.4 , Pg.5 ]

See also in sourсe #XX -- [ Pg.162 ]

See also in sourсe #XX -- [ Pg.30 , Pg.43 , Pg.202 ]

See also in sourсe #XX -- [ Pg.74 ]

See also in sourсe #XX -- [ Pg.459 ]

See also in sourсe #XX -- [ Pg.638 ]

See also in sourсe #XX -- [ Pg.4 ]

See also in sourсe #XX -- [ Pg.428 , Pg.502 , Pg.531 ]

See also in sourсe #XX -- [ Pg.160 , Pg.199 ]

See also in sourсe #XX -- [ Pg.96 , Pg.97 ]

See also in sourсe #XX -- [ Pg.96 ]

See also in sourсe #XX -- [ Pg.127 ]

See also in sourсe #XX -- [ Pg.234 , Pg.235 , Pg.236 , Pg.237 ]

See also in sourсe #XX -- [ Pg.366 ]

See also in sourсe #XX -- [ Pg.74 , Pg.124 , Pg.125 ]

See also in sourсe #XX -- [ Pg.68 , Pg.213 , Pg.382 ]

See also in sourсe #XX -- [ Pg.638 ]

See also in sourсe #XX -- [ Pg.308 , Pg.310 ]

See also in sourсe #XX -- [ Pg.99 , Pg.161 ]

See also in sourсe #XX -- [ Pg.146 ]

See also in sourсe #XX -- [ Pg.16 , Pg.17 , Pg.27 ]

See also in sourсe #XX -- [ Pg.3 , Pg.1908 ]

See also in sourсe #XX -- [ Pg.162 ]

See also in sourсe #XX -- [ Pg.125 ]

See also in sourсe #XX -- [ Pg.118 , Pg.162 , Pg.167 , Pg.168 , Pg.173 , Pg.181 , Pg.185 , Pg.189 , Pg.190 , Pg.191 ]

See also in sourсe #XX -- [ Pg.13 ]

See also in sourсe #XX -- [ Pg.11 , Pg.156 ]

See also in sourсe #XX -- [ Pg.115 ]

See also in sourсe #XX -- [ Pg.71 ]

See also in sourсe #XX -- [ Pg.459 ]

See also in sourсe #XX -- [ Pg.569 ]

See also in sourсe #XX -- [ Pg.357 ]




SEARCH



Anti-epidermal growth factor

Breast Cancer Human Epidermal Growth Factor Tyrosine Kinase Inhibitors

Breast cancer human epidermal growth factor receptor

Breast tumors epidermal growth factor receptor

Calcium-binding epidermal growth factor

Cancer epidermal growth factor

Cancer human epidermal growth factor

Dimerization epidermal growth factor receptors

EGFR (epidermal growth factor

EGFR (epidermal growth factor breast cancer

EGFR (epidermal growth factor erlotinib gefitinib

EGFR (epidermal growth factor inhibitor selectivity

EGFR (epidermal growth factor kinase activation

Epidermal

Epidermal Growth Factor Receptor 2 (ErbB

Epidermal growth factor (EGF)

Epidermal growth factor , receptor

Epidermal growth factor -derived

Epidermal growth factor -like domains, calcium-binding proteins

Epidermal growth factor Drosophila with

Epidermal growth factor amino-acid sequence

Epidermal growth factor and

Epidermal growth factor biological activities

Epidermal growth factor brain development

Epidermal growth factor carcinogenesis

Epidermal growth factor cell culture

Epidermal growth factor cell membrane binding

Epidermal growth factor cell-surface receptors

Epidermal growth factor cells

Epidermal growth factor cells targeted

Epidermal growth factor cellular mechanisms

Epidermal growth factor comparison

Epidermal growth factor cysteine richness

Epidermal growth factor decreased dependence

Epidermal growth factor family

Epidermal growth factor fluorescent

Epidermal growth factor interaction

Epidermal growth factor introduction

Epidermal growth factor ligand binding with

Epidermal growth factor ligand-induced dimerization

Epidermal growth factor mitogenicity

Epidermal growth factor modules

Epidermal growth factor precursor

Epidermal growth factor precursor homology domain

Epidermal growth factor radiosensitizer

Epidermal growth factor receptor (EGFR

Epidermal growth factor receptor , and

Epidermal growth factor receptor Drosophila with

Epidermal growth factor receptor EGER)

Epidermal growth factor receptor HeLa cells

Epidermal growth factor receptor Herceptin with

Epidermal growth factor receptor anti-HER2 antibodies with

Epidermal growth factor receptor cancer associated with

Epidermal growth factor receptor family

Epidermal growth factor receptor family targeting

Epidermal growth factor receptor gene

Epidermal growth factor receptor ligand binding

Epidermal growth factor receptor ligand-induced dimerization

Epidermal growth factor receptor ligand-induced signaling

Epidermal growth factor receptor ligands

Epidermal growth factor receptor mediated pathways, inhibition

Epidermal growth factor receptor molecular targeting

Epidermal growth factor receptor naming

Epidermal growth factor receptor oncogene

Epidermal growth factor receptor proliferation mechanisms

Epidermal growth factor receptor prostate cancer

Epidermal growth factor receptor signaling

Epidermal growth factor receptor signaling pathway

Epidermal growth factor receptor structure

Epidermal growth factor receptor structure/function

Epidermal growth factor receptor testing

Epidermal growth factor receptor therapeutic targeting

Epidermal growth factor receptor transactivation

Epidermal growth factor receptor tyrosine kinase

Epidermal growth factor receptor uniqueness

Epidermal growth factor receptor, cancer protection

Epidermal growth factor receptors EGFR mutants

Epidermal growth factor receptors biochemistry

Epidermal growth factor receptors cancer

Epidermal growth factor receptors interacting proteins

Epidermal growth factor receptors irreversible inhibitors

Epidermal growth factor receptors model

Epidermal growth factor receptors mutations

Epidermal growth factor structure/function

Epidermal growth factor subfamily

Epidermal growth factor therapy studies

Epidermal growth factor, murine

Epidermal growth factors ErbB binding

Epidermal growth factors ErbB signaling

Epidermal growth factors receptor, identification

Estimation of Epidermal Growth Factor Receptor Expression

HER2 (human epidermal growth factor receptor

Heparin-binding epidermal growth factor

Heparin-binding epidermal growth factor HB-EGF)

Human epidermal growth factor

Human epidermal growth factor coupling

Human epidermal growth factor receptor

Human epidermal growth factor receptor 2 (HER

Human epidermal growth factor requirements

Recombinant human epidermal growth factor

Signal transduction epidermal growth factor

Structure of epidermal growth factor

© 2024 chempedia.info